As of 2026-09-17, the Fair Value of Kymera Therapeutics Inc (KYMR) is -18.21 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 116.33 USD, the upside of Kymera Therapeutics Inc is -115.65%.
With the market price of 116.33 USD and our fair value calculation, Kymera Therapeutics Inc (KYMR) is not a good investment. Investing in KYMR stocks now will result in a potential loss of 115.65%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -100.22 | -154.81 | -146.96 | -223.86 | -311.35 | -187.44 |
| YoY growth | -119.83% | -54.47% | 5.07% | -52.32% | -39.08% | -52.13% |
| Market Cap (mil) | 9,569.31 |
| P/E | |
| Forward P/E |
| EPS | -3.64 |
| Avg earnings growth rate | -52.13% |
| TTM earnings | -299.60 |